|1.||Hamvas, Aaron: 8 articles (12/2009 - 06/2006)|
|2.||Whitsett, Jeffrey A: 7 articles (08/2009 - 06/2002)|
|3.||Monteiro, Renato C: 6 articles (08/2015 - 10/2002)|
|4.||Nogee, Lawrence M: 6 articles (12/2009 - 10/2005)|
|5.||Cole, F Sessions: 6 articles (12/2009 - 10/2006)|
|6.||Xu, Tao: 4 articles (08/2015 - 08/2011)|
|7.||Chai, Andrea: 4 articles (03/2015 - 01/2008)|
|8.||Pennetta, Giuseppa: 4 articles (03/2015 - 01/2008)|
|9.||Moura, Ivan C: 4 articles (04/2012 - 10/2002)|
|10.||Wegner, Daniel J: 4 articles (12/2009 - 08/2007)|
10/16/2015 - "Further study revealed that knockdown of CPEB4 decreased the expression of anti-apoptotic protein B-cell lymphoma-extra large (Bcl-XL), but enhanced the expression of B-cell lymphoma-2-associated X (Bax). "
01/01/2013 - "In this study, we discovered a novel mechanism mediated by microRNA-129 (miR-129) to trigger apoptosis by suppressing a key anti-apoptotic protein, B-cell lymphoma 2 (BCL2). "
12/01/2012 - "In this study we report that deficiency of the adaptor protein B cell lymphoma 10 (Bcl10) impaired the ability of BAFF to support B cell survival in vitro, and it specifically increased apoptosis in anergic B cells in vivo, dramatically reducing anergic B cells in mice. "
07/01/2012 - "Recent studies revealed an association between the brain anti-apoptotic protein B cell lymphoma like X, long variant (Bcl-xL) expression and individual differences in behavioral vulnerability to stress. "
06/15/1990 - "Studies with lymphomas, hybridomas, Ag-specific clones and activated normal splenic T cells identified many examples of CD4 and CD8 lineage cells that constitutively expressed IgA receptors. "
|2.||Breast Neoplasms (Breast Cancer)
01/01/2012 - "VAMP-associated protein B (VAPB) promotes breast tumor growth by modulation of Akt activity."
02/01/2015 - "BITC treatment resulted in a marked decrease in protein level of polycomb group protein B-lymphoma Moloney murine leukemia virus insertion region-1 (Bmi-1) in cultured human breast cancer cells (MCF-7, SUM159, MDA-MB-231, and MDA-MB-361) and MDA-MB-231 xenografts in vivo. "
12/14/2004 - "Importantly, it provides a significant improvement over all previous methods for monitoring [Ca(2+)](ER) and has been used to directly show that, in MCF-7 breast cancer cells, the antiapoptotic protein B cell lymphoma 2 (Bcl-2) (i) lowers [Ca(2+)](ER) by increasing Ca(2+) leakage under resting conditions and (ii) alters Ca(2+) oscillations induced by ATP, and that acute inhibition of Bcl-2 by the green tea compound epigallocatechin gallate results in an increase in [Ca(2+)](ER) due to inhibition of Bcl-2-mediated Ca(2+) leakage."
04/01/2010 - "Glembatumumab vedotin, a conjugate of an anti-glycoprotein non-metastatic melanoma protein B mAb and monomethyl auristatin E for the treatment of melanoma and breast cancer."
05/01/2011 - "The influence of genetic variation in surfactant protein B on severe lung injury in African American children."
06/01/2005 - "Surfactant protein B (SP-B) is required for function of newborn and adult lung, and partial deficiency has been associated with susceptibility to lung injury. "
01/01/2004 - "Polymorphism in the surfactant protein-B gene, gender, and the risk of direct pulmonary injury and ARDS."
08/15/2001 - "Although the initial lung injury score was not predictive of ARDS, the initial plasma surfactant protein-B was predictive (area under the curve = 0.77 [0.63 to 0.90], nonparametric receiver-operating characteristic analysis). "
10/01/1999 - "Surfactant protein-B-deficient mice are susceptible to hyperoxic lung injury."
|4.||Melanoma (Melanoma, Malignant)
09/01/2012 - "Expression of glycoprotein non-metastatic melanoma protein B in cutaneous malignant and benign lesions: a tissue microarray study."
10/01/2015 - "We previously reported that glycoprotein nonmetastatic melanoma protein B (GPNMB; osteoactivin) might serve as a target for ALS therapy. "
02/01/2015 - "Glycoprotein nonmetastatic melanoma protein B (GPNMB), a transmembrane protein, has been reported to have an important role in tissue repair and angiogenesis. "
01/01/2015 - "Glycoprotein (transmembrane) nonmetastatic melanoma protein b (GPNMB) plays crucial roles in odontogenesis. "
12/01/2013 - "Glycoprotein non-metastatic melanoma protein B (GPNMB) is known to be vital in bone formation. "
05/01/2005 - "In this study, we examined human and mouse neutrophil-mediated tumor cell lysis via targeting the IgA FcR, FcalphaRI (CD89), in more detail. "
12/01/2010 - "Importantly, HSP90 inhibitors are predominantly being recognized as "tumor cell targeting" agents since cancer cells a) overexpress HSP90 protein, b) highly rely on HSP90 function for maintaining oncogenic signaling, and c) HSP90 inhibitors bind with high affinity to HSP90 in tumor cells. "
07/01/1982 - "Normal prostate revealed a pattern similar to the G tumor except that Protein b appeared to be quantitatively reduced. "
07/01/1982 - "One high-molecular-weight protein (Protein b) present on the G tumor was absent from the H tumor. "
08/28/2015 - "Bmi1, the polycomb group protein B lymphoma Mo-MLV insertion region 1 homolog, regulates EMT transition, maintains the self-renewal capacity of stem cells, and is frequently overexpressed in human cancers. "
|3.||Surface-Active Agents (Surfactants)
|5.||Immunoglobulin A (IgA)
|6.||Adenosine Triphosphate (ATP)
|8.||Nitric Oxide (Nitrogen Monoxide)
|1.||Heterologous Transplantation (Xenotransplantation)
|4.||Renal Dialysis (Hemodialysis)